STANDARDIZATION OF SKELETAL-MUSCLE ISCHEMIC-INJURY

被引:21
|
作者
COLBURN, MD [1 ]
QUINONESBALDRICH, WJ [1 ]
GELABERT, HA [1 ]
NOWARA, H [1 ]
MOORE, WS [1 ]
机构
[1] UNIV CALIF LOS ANGELES,CTR HLTH SCI,DIV VASC SURG,LOS ANGELES,CA 90024
关键词
D O I
10.1016/0022-4804(92)90108-C
中图分类号
R61 [外科手术学];
学科分类号
摘要
Observations on skeletal muscle function after a timed ischemic interval suggests significant interanimal variability. The purpose of this study is to compare the use of function versus time as a method for standardizing the degree of ischemic injury. Muscle function was measured by recording the isometric contraction to direct supramaximal tetanic stimulation of the anterior tibialis muscle (AT). Muscle cell viability was determined by the reduction of triphenyltetrazolium chloride (TTC)/g tissue measured by a spectrophotometric assay. Twenty-four New Zealand White rabbits underwent an interval of ischemia to one anterior tibialis muscle produced by collateral ligation and unilateral inflow control, using the contralateral AT as a control. The duration of ischemia was determined by one of three methods: Group I, n = 8, underwent ischemia for 3 hr (3 hr); Group II, n = 8, underwent ischemia until AT muscle function decreased to 20% of control (20%); and Group III, n = 8, underwent ischemia until AT muscle function decreased to <5% of control (<5%). Following the ischemic injury, both physiologic function and cellular viability were measured and expressed as a percentage of control. After 3 hr of ischemia, the mean function was 15.5 with a standard deviation of 20.2, and the TTC reduced/g tissue was 24.7 with a standard deviation of 24.8. When the ischemic interval was determined by a decline of muscle function to 20% of control, the mean TTC reduced was 33.4 ± 7.6. The mean TTC reduced, when the ischemic interval was terminated when muscle function reached <5% of control, was 13.5 ± 7.2. There is a high degree of correlation between the percentage function and the percentage TTC reduced for each animal (r = 0.933). When time is used to standardize an ischemic interval there is a large degree of variability in the resulting cellular viability (SD = 24.8). This difference was significantly reduced (P < 0.01) in both the 20 and <5% groups by use of function as a physiologic endpoint to mark the duration of the ischemic insult (SD = 7.6 and 7.2). We conclude that because of interanimal variability, use of function is superior to a predetermined timed ischemic interval as a method of standardizing the degree of an ischemic insult in skeletal muscle. © 1992.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 50 条
  • [1] DETERMINANTS OF ISCHEMIC-INJURY TO SKELETAL-MUSCLE
    PETRASEK, PF
    HOMERVANNIASINKAM, S
    WALKER, PM
    JOURNAL OF VASCULAR SURGERY, 1994, 19 (04) : 623 - 631
  • [2] THE ROLE OF LEUKOCYTES IN THE PATHO-PHYSIOLOGY OF SKELETAL-MUSCLE ISCHEMIC-INJURY
    BELKIN, M
    LAMORTE, WL
    WRIGHT, JG
    HOBSON, RW
    JOURNAL OF VASCULAR SURGERY, 1989, 10 (01) : 14 - 19
  • [3] EVALUATION OF ISCHEMIC-INJURY IN SKELETAL-MUSCLE BY P-31 NMR - AN EXPERIMENTAL-STUDY IN RATS
    AUTHIER, B
    ALBRAND, JP
    DECORPS, M
    LAURENT, D
    ROSSI, A
    INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL, 1988, 7 (03): : 264 - 264
  • [4] SALVAGE OF ISCHEMIC SKELETAL-MUSCLE FROM REPERFUSION INJURY
    PANG, CY
    DORION, D
    ZHONG, AG
    CHIU, C
    FASEB JOURNAL, 1991, 5 (05): : A1274 - A1274
  • [5] FUNCTIONAL ASSESSMENT AND PROTECTION OF ISCHEMIC - REPERFUSION INJURY IN SKELETAL-MUSCLE
    OFARRELL, DA
    CHEN, LE
    SEABER, AV
    DAVIES, MG
    HAGEN, PO
    URBANIAK, JR
    FASEB JOURNAL, 1993, 7 (04): : A806 - A806
  • [6] PROTECTION OF THE ISCHEMIC SKELETAL-MUSCLE
    BEYERSDORF, F
    THORACIC AND CARDIOVASCULAR SURGEON, 1991, 39 (01): : 19 - 28
  • [7] PREDICTION BY P-31-NMR OF THE IRREVERSIBILITY OF ISCHEMIC-INJURY IN RAT SKELETAL-MUSCLE AFTER LIGATION OF THE FEMORAL-ARTERY
    AUTHIER, B
    ROSSI, A
    ALBRAND, JP
    DECORPS, M
    MUSCLE & NERVE, 1989, 12 (01) : 20 - 25
  • [8] THE ABILITY OF OXYGENATED FLUOROCARBON SOLUTION TO MINIMIZE ISCHEMIC SKELETAL-MUSCLE INJURY
    TAKAHASHI, F
    TSAI, TM
    FLEMING, PE
    OGDEN, L
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1987, 80 (04) : 582 - 590
  • [9] REPERFUSION INJURY IN SKELETAL-MUSCLE
    OREDSSON, S
    PLATE, G
    QVARFORDT, P
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 2831 - 2833
  • [10] ISCHEMIC TOLERANCE OF HUMAN SKELETAL-MUSCLE
    ECKERT, P
    SCHNACKERZ, K
    ANNALS OF PLASTIC SURGERY, 1991, 26 (01) : 77 - 84